Search for: "DNA Diagnostics, Inc."
Results 121 - 140
of 156
Sorted by Relevance
|
Sort by Date
22 Apr 2016, 1:08 pm
Sequenom (2015), the Federal Circuit held that under Mayo, a diagnostic process based on the discovery of cell-free fetal DNA in the maternal bloodstream was not patent-eligible under § 101, because the steps of amplifying and detecting DNA were conventional at the time the invention was made. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in… [read post]
25 Dec 2018, 10:00 pm
Vanda Pharmaceuticals Inc. v. [read post]
13 May 2009, 8:00 pm
Amgen Inc. v. [read post]
11 Feb 2010, 7:41 pm
Investigators are using DNA analysis of Salmonella bacteria obtained through diagnostic testing to identify cases of illness that may be part of this outbreak. [read post]
31 Jul 2011, 9:28 pm
" MedImmune, Inc. v. [read post]
5 Apr 2011, 4:00 am
The goal of a new diagnostic test is to find the cancer early enough to effectively treat it, according to Harvey I. [read post]
15 Dec 2010, 7:36 am
Both of those cases (Classen Immunotherapies, Inc. v. [read post]
19 May 2019, 9:04 pm
Polymerase Chain Reaction (PCR)“PCR is defined as a technique in molecular genetics that permits the analysis of any short sequence of DNA, or RNA – even in samples containing minute quantities of DNA or RNA. [read post]
9 Jul 2012, 6:27 am
Optigen, which provides DNA-based diagnostic services to test for inherited diseases in dogs, sued defendants for patent infringement as well as false advertising/unfair competition. [read post]
5 May 2017, 10:00 pm
” Investigators reported to CDC that there were two additional ill people who either developed HUS or had a diagnostic test showing they were infected with E. coli bacteria. [read post]
20 Apr 2024, 8:18 pm
Myriad Genetics, Inc., that “a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated. [read post]
10 Oct 2017, 9:30 am
Ariosa Diagnostics, Inc. [read post]
28 Oct 2014, 5:29 pm
Public health investigators used DNA “fingerprints” of Listeria obtained through diagnostic testing with pulsed-field gel electrophoresis, or PFGE, to identify cases of illness that were part of this outbreak. [read post]
7 Jul 2015, 10:01 pm
The single-stranded DNA molecules bind to the pathogens in a sample. [read post]
9 Jan 2014, 8:17 am
In addition to other clinical studies evaluating Trovagene’s novel molecular diagnostics, the US Oncology Research collaboration is the first multi-site study sponsored by Trovagene. [read post]
20 Jul 2010, 2:31 pm
Biogen Idec. involves a diagnostic method. [read post]
18 May 2016, 8:19 am
Ariosa Diagnostics, Inc., et al., No. 15-1182 (scope of the natural phenomenon eligibility exclusion) Eligibility Challenges: Vehicle Intelligence and Safety LLC v. [read post]
12 Dec 2014, 7:21 pm
Public health investigators used DNA “fingerprints” of Salmonella bacteria obtained through diagnostic testing with pulsed-field gel electrophoresis (PFGE) to identify patients considered to be part of the outbreak. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
